Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Cholvax

PreclinicalBiologic

IInternational Centre for Diarrhoeal Disease Research, Bangladesh

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

CholeraRecruiting

CholeraPreclinical

Recruiting

Timeline

Expected Milestones

Q4 2029

PreclinicalRecruiting

Cholera

NCT07685574

Clinical

Trials by Indication[1]

Immunogenicity1 trial

Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 2·NCT02742558·2,052 enrolled

Cholera1 trial

Case-area Targeted Interventions (CATIs) Among Household Contacts and Neighbouring Households After Defining Cholera Hotspot Areas in Bangladesh: The Effectiveness of OCV and Potential Impact on Cholera Control

Recruiting·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Preclinical·NCT07685574·68,400 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Cholvax. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cholvax compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cholvax. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — International Centre for Diarrhoeal Disease Research, Bangladesh company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: IInternational Centre for Diarrhoeal Disease Research, Bangladesh

Related News